Page last updated: 2024-08-23

sq-11725 and Hematochezia

sq-11725 has been researched along with Hematochezia in 52 studies

Research

Studies (52)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (9.62)	18.7374
1990's	7 (13.46)	18.2507
2000's	29 (55.77)	29.6817
2010's	11 (21.15)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hayes, P; Robertson, M	1
Bendtsen, F; Gluud, LL; Hobolth, L; Jeyaraj, R; Morgan, MY; Zacharias, AP	1
Bai, M; Fan, D; Han, G; Qi, X; Yang, M	1
Advani, S; Cao, Y; El-Serag, HB; Kanwal, F; Kramer, J; Shukla, R; Tansel, A; Walder, A; Ying, J	1
Chan, HH; Chen, TA; Chen, WC; Hsu, PI; Lai, KH; Lin, CK; Lo, GH; Tsai, WL; Yu, HC	1
Aracil, C; Balanzo, J; Colomo, A; Gonzalez, B; Guarner, C; Lopez-Balaguer, JM; Piqueras, M; Torras, X; Villanueva, C	1
Abraldes, JG; Albillos, A; Bañares, R; Bosch, J; García-Pagán, JC; Morillas, R; Villanueva, C	1
Alvarez-Urturi, C; Aracil, C; Balanzó, J; Colomo, A; Guarner, C; Hernández-Gea, V; López-Balaguer, JM; Torras, X; Villanueva, C	1
Altamirano, JT; Augustin, S; Esteban, R; Genescà, J; González, A; Guardia, J; Muntaner, L	1
Chen, WC; Lee, CC; Lo, GH; Wang, HM	1
Abraldes, JG; Berzigotti, A; Bosch, J; Garcia-Pagan, JC; Saez, R; Tandon, P	1
Talwalkar, JA	1
Abu-Suboh, M; Armengol, JR; Augustin, S; Dot, J; Esteban, R; Genescà, J; González, A; Guardia, J; Pérez, M; Romero, A; Segarra, A	1
Choe, WH; Kim, JH; Ko, SY; Kwon, SY; Lee, CH	1
Chen, WC; Lo, GH; Wang, HM; Yu, HC	1
Lock, G; Messmann, H; Wiest, R	1
Bissoli, F; Borroni, G; Cazzaniga, M; de Franchis, R; Lorenzano, E; Maggi, A; Panzeri, A; Salerno, F; Visentin, S	1
Barkin, JS; Maldonado, D	1
Chen, MH; Chen, WC; Hsu, PI; Lai, KH; Lin, CK; Lo, GH; Tsai, WL	1
Chen, MH; Chen, WC; Cheng, JS; Hsu, PI; Lai, KH; Lin, CP; Lo, CC; Lo, GH	1
Gawrieh, S; Saeian, K	1
Bhaskar, ME	1
Angeli, P; Bellini, B; Bernardinello, E; Bolognesi, M; Cavallarin, G; Donada, C; Felder, M; Gatta, A; Marin, R; Merkel, C; Torboli, P; Zanella, P	1
Mann, NS	1
Brullet, E; de la Peña, J; Garcia Suárez, C; Martin-Lorente, JL; Rivero, M; Sanchez-Hernández, E; Vergara, M	1
Gupta, R; Sarin, SK; Shahi, H; Wadhawan, M	1
Balanzo, J; Cusso, X; Gallego, A; Gonzalez-Suarez, B; Guarner, C; Minana, J; Sainz, S; Soriano, G; Torras, X; Villanueva, C	1
Stiegmann, GV	1
Argonz, J; Bosco, A; Dominguez, N; Fassio, E; Kravetz, D; Muñoz, A; Romero, G; Salgado, P; Suarez, A; Terg, R; Vulcano, C	1
Armengol, JR; Augustin, S; Dot, J; Esteban, R; Genescà, J; González, A; Guardia, J; Malagelada, JR; Pérez, M; Saperas, E; Segarra, A; Tomasello, A	1
Laleman, W; Nevens, F	1
Chan, HH; Chen, WC; Cheng, LC; Hsu, PI; Lai, KH; Lo, GH; Tsai, WL; Wang, HM	1
Battaglia, G; Gatta, A; Merkel, C; Milani, L; Sacerdoti, D; Zuin, R	1
Balanzó, J; González, D; Martínez, FJ; Sáinz, S; Soriano, G; Torras, X; Villanueva, C	1
Balanzó, J; Cussó, X; Guarner, C; Novella, MT; Sáinz, S; Soriano, G; Torras, X; Vilardell, F; Villanueva, C	1
Chambliss, ML; Stevermer, JJ	1
Amodio, P; Bolognesi, M; Cavallarin, G; Donada, C; Felder, M; Gatta, A; Marin, R; Mazzaro, C; Merkel, C; Sacerdoti, D; Sebastianelli, G; Torboli, P	1
Bosch, J	1
Chen, MH; Cheng, JS; Hsu, PI; Huang, HC; Lai, KH; Lin, CK; Lo, GH	1
Assi, SA; Sanyal, A; Schubert, ML	1
Herrera, JL; Zalepuga, R	1
Balanzó, J; Boadas, J; Cussó, X; Gallego, A; Guarner, C; Miñana, J; Ortiz, J; Sáinz, S; Soriano, G; Torras, X; Villanueva, C	1
Novick, DM	1
Blendis, L; Wong, F	1
Elder, CA; Restino, MS	1
Calès, P; Ideo, G; Lebrec, D; Pagliaro, L; Pascal, JP; Pasta, L; Poynard, T	1
Gatta, A; Merkel, C; Sacerdoti, D	1
Bedogni, G; Beltrami, M; Bertoni, G; Castagnetti, E; Conigliaro, R; Fornaciari, G; Grazia Mortilla, M; Plancher, AC; Ricci, E	1
Ohara, N; Reichen, J	1
Bode, JC; Teltscher, U; Walker, S	1
Benhamou, JP; Capron, JP; Chaput, JC; Geoffroy, P; Hillon, P; Lebrec, D; Poynard, T; Roulot, D; Rueff, B	1
Angeli, P; Bolognesi, M; Caregaro, L; Gatta, A; Merkel, C; Ruol, A; Sacerdoti, D; Zuin, R	1

Reviews

9 review(s) available for sq-11725 and Hematochezia

Article	Year
Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices. The Cochrane database of systematic reviews, 2018, Oct-29, Volume: 10 Topics: Adrenergic beta-Antagonists; Adult; Carvedilol; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Nadolol; Primary Prevention; Propranolol; Randomized Controlled Trials as Topic; Secondary Prevention	2018
Combined therapies versus monotherapies for the first variceal bleeding in patients with high-risk varices: a meta-analysis of randomized controlled trials. Journal of gastroenterology and hepatology, 2014, Volume: 29, Issue:3 Topics: Combined Modality Therapy; Databases, Bibliographic; Drug Therapy, Combination; Endpoint Determination; Esophageal and Gastric Varices; Follow-Up Studies; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Isosorbide Dinitrate; Nadolol; Propranolol; Randomized Controlled Trials as Topic; Risk; Spironolactone	2014
Pharmacotherapy alone vs endoscopic variceal ligation combination for secondary prevention of oesophageal variceal bleeding: meta-analysis. Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32, Issue:5 Topics: Adrenergic beta-Antagonists; Combined Modality Therapy; Esophageal and Gastric Varices; Esophagoscopy; Gastrointestinal Hemorrhage; Humans; Ligation; Nadolol; Propranolol; Randomized Controlled Trials as Topic; Survival Rate; Treatment Outcome	2012
Evolution of endoscopic therapy for esophageal varices. Surgical endoscopy, 2006, Volume: 20 Suppl 2 Topics: Adrenergic beta-Antagonists; Combined Modality Therapy; Endoscopy, Digestive System; Esophageal and Gastric Varices; Forecasting; Gastrointestinal Hemorrhage; Humans; Ligation; Meta-Analysis as Topic; Nadolol; Prospective Studies; Randomized Controlled Trials as Topic; Sclerotherapy; Sucralfate; Treatment Outcome; Vasoconstrictor Agents	2006
Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding. Minerva medica, 2006, Volume: 97, Issue:4 Topics: Adrenergic beta-Antagonists; Animals; Contraindications; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Follow-Up Studies; Forecasting; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Middle Aged; Nadolol; Portasystemic Shunt, Surgical; Portasystemic Shunt, Transjugular Intrahepatic; Practice Guidelines as Topic; Propranolol; Randomized Controlled Trials as Topic; Rats; Risk Factors; Risk Reduction Behavior; Splanchnic Circulation; Stents; Time Factors; Vascular Resistance; Vasodilator Agents	2006
The sixth Carlos E. Rubio Memorial Lecture. Prevention and treatment of variceal hemorrhage. Puerto Rico health sciences journal, 2000, Volume: 19, Issue:1 Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Double-Blind Method; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Liver Transplantation; Lypressin; Middle Aged; Mineralocorticoid Receptor Antagonists; Nadolol; Nitric Oxide Donors; Nitroglycerin; Portasystemic Shunt, Transjugular Intrahepatic; Propranolol; Randomized Controlled Trials as Topic; Recurrence; Sclerotherapy; Spironolactone; Terlipressin; Vasoconstrictor Agents; Vasodilator Agents	2000
Beta-adrenergic antagonists for primary prevention of gastrointestinal hemorrhage in patients with cirrhosis and esophageal varices. Clinical pharmacy, 1992, Volume: 11, Issue:4 Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Nadolol; Propranolol	1992
Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter The New England journal of medicine, 1991, May-30, Volume: 324, Issue:22 Topics: Adrenergic beta-Antagonists; Ascites; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Meta-Analysis as Topic; Middle Aged; Nadolol; Prognosis; Propranolol	1991
Pharmacological therapy of portal hypertension. Digestive diseases (Basel, Switzerland), 1986, Volume: 4, Issue:4 Topics: Acute Disease; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hypertension, Portal; Nadolol; Propranolol; Somatostatin; Vasopressins	1986

Trials

29 trial(s) available for sq-11725 and Hematochezia

Article	Year
Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding. Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:2 Topics: Adrenergic beta-Antagonists; Adult; Aged; Digestive System Surgical Procedures; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Kaplan-Meier Estimate; Ligation; Male; Middle Aged; Nadolol; Secondary Prevention; Treatment Outcome; Vasodilator Agents	2008
Clinical trial: a randomized controlled study on prevention of variceal rebleeding comparing nadolol + ligation vs. hepatic venous pressure gradient-guided pharmacological therapy. Alimentary pharmacology & therapeutics, 2009, Feb-15, Volume: 29, Issue:4 Topics: Antihypertensive Agents; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Secondary Prevention; Venous Pressure	2009
Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial. Gut, 2009, Volume: 58, Issue:8 Topics: Adrenergic beta-Antagonists; Adult; Aged; Combined Modality Therapy; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Male; Middle Aged; Nadolol; Prospective Studies; Secondary Prevention; Survival Analysis; Treatment Outcome; Vasodilator Agents	2009
Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding. Gastroenterology, 2009, Volume: 137, Issue:1 Topics: Adrenergic beta-Antagonists; Aged; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hypertension, Portal; Kaplan-Meier Estimate; Liver Cirrhosis; Male; Middle Aged; Nadolol; Portal Pressure; Predictive Value of Tests; Proportional Hazards Models; Propranolol; Risk Assessment; ROC Curve; Time Factors; Treatment Outcome	2009
High doses of beta-blockers and alcohol abstinence improve long-term rebleeding and mortality in cirrhotic patients after an acute variceal bleeding. Liver international : official journal of the International Association for the Study of the Liver, 2010, Volume: 30, Issue:8 Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Cohort Studies; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Nadolol; Regression Analysis; Temperance	2010
Controlled trial of ligation plus nadolol versus nadolol alone for the prevention of first variceal bleeding. Hepatology (Baltimore, Md.), 2010, Volume: 52, Issue:1 Topics: Adrenergic beta-Antagonists; Aged; Combined Modality Therapy; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Ligation; Male; Middle Aged; Nadolol	2010
Adding banding ligation is effective as rescue therapy to prevent variceal rebleeding in haemodynamic non-responders to pharmacological therapy. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2012, Volume: 44, Issue:1 Topics: Acute Disease; Aged; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Secondary Prevention; Somatostatin; Treatment Outcome	2012
Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding. Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:11 Topics: Adult; Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilol; Chi-Square Distribution; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemostasis, Endoscopic; Humans; Hypertension, Portal; Isosorbide Dinitrate; Kaplan-Meier Estimate; Ligation; Male; Middle Aged; Nadolol; Propanolamines; Proportional Hazards Models; Secondary Prevention; Vasodilator Agents	2012
Nadolol is superior to isosorbide mononitrate for the prevention of the first variceal bleeding in cirrhotic patients with ascites. Journal of hepatology, 2002, Volume: 37, Issue:3 Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Ascites; Blood Pressure; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Heart Rate; Humans; Isosorbide Dinitrate; Kidney; Liver Cirrhosis; Male; Middle Aged; Nadolol; Survival Rate; Treatment Outcome; Vasodilator Agents	2002
Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding. Gastroenterology, 2002, Volume: 123, Issue:3 Topics: Adult; Antihypertensive Agents; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Male; Middle Aged; Nadolol; Secondary Prevention; Treatment Failure; Vasodilator Agents	2002
Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis. Gastrointestinal endoscopy, 2004, Volume: 59, Issue:3 Topics: Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Esophageal and Gastric Varices; Esophagoscopy; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Ligation; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Nadolol; Probability; Proportional Hazards Models; Recurrence; Risk Assessment; Severity of Illness Index; Treatment Outcome	2004
A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology, 2004, Volume: 127, Issue:2 Topics: Adrenergic beta-Antagonists; Aged; Disease-Free Survival; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Nadolol; Placebos	2004
Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial. Hepatology (Baltimore, Md.), 2005, Volume: 41, Issue:3 Topics: Adrenergic beta-Antagonists; Adult; Aged; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Ligation; Male; Middle Aged; Nadolol; Prospective Studies; Recurrence	2005
Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients. Digestive diseases and sciences, 2005, Volume: 50, Issue:8 Topics: Adult; Antihypertensive Agents; Drug Therapy, Combination; Endoscopy, Digestive System; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Propranolol; Secondary Prevention; Vasodilator Agents	2005
Pharmacologic treatment of portal hypertension in the prevention of community-acquired spontaneous bacterial peritonitis. European journal of gastroenterology & hepatology, 2006, Volume: 18, Issue:1 Topics: Adrenergic beta-Antagonists; Bacterial Infections; Community-Acquired Infections; Drug Therapy, Combination; Epidemiologic Methods; Esophageal and Gastric Varices; Esophagoscopy; Female; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Male; Middle Aged; Nadolol; Peritonitis; Sclerotherapy; Secondary Prevention; Vasodilator Agents	2006
Comparative study between nadolol and 5-isosorbide mononitrate vs. endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial. Alimentary pharmacology & therapeutics, 2006, Aug-15, Volume: 24, Issue:4 Topics: Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Sclerotherapy; Secondary Prevention	2006
Hemodynamic response-guided therapy for prevention of variceal rebleeding: an uncontrolled pilot study. Hepatology (Baltimore, Md.), 2006, Volume: 44, Issue:4 Topics: Adrenergic beta-Antagonists; Dose-Response Relationship, Drug; Female; Gastrointestinal Hemorrhage; Hepatic Veins; Humans; Ligation; Liver Circulation; Liver Cirrhosis; Male; Middle Aged; Nadolol; Pilot Projects; Portasystemic Shunt, Transjugular Intrahepatic; Secondary Prevention; Venous Pressure	2006
Comparison of endoscopic variceal ligation and nadolol plus isosorbide-5-mononitrate in the prevention of first variceal bleeding in cirrhotic patients. Journal of the Chinese Medical Association : JCMA, 2006, Volume: 69, Issue:10 Topics: Adult; Aged; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Male; Middle Aged; Nadolol	2006
[Nadolol as an adjuvant to sclerotherapy of esophageal varices for prevention of recurrent hemorrhaging]. Revista espanola de enfermedades digestivas, 1994, Volume: 86, Issue:1 Topics: Adult; Aged; Combined Modality Therapy; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Nadolol; Prospective Studies; Recurrence; Sclerotherapy	1994
Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. The New England journal of medicine, 1996, Jun-20, Volume: 334, Issue:25 Topics: Actuarial Analysis; Adrenergic beta-Antagonists; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nadolol; Recurrence; Sclerotherapy; Survival Analysis; Treatment Outcome; Vasodilator Agents	1996
Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Hepatology (Baltimore, Md.), 2000, Volume: 31, Issue:2 Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Ascites; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Nadolol; Randomized Controlled Trials as Topic	2000
Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology (Baltimore, Md.), 2000, Volume: 32, Issue:3 Topics: Adrenergic beta-Antagonists; Adult; Anti-Ulcer Agents; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Ligation; Male; Middle Aged; Nadolol; Postoperative Complications; Prospective Studies; Sclerotherapy; Secondary Prevention; Sucralfate; Survival Analysis; Treatment Outcome	2000
Should nitrates be used with beta blockers to prevent variceal bleeding? The American journal of gastroenterology, 2000, Volume: 95, Issue:10 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Nadolol; Vasodilator Agents	2000
Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. The New England journal of medicine, 2001, Aug-30, Volume: 345, Issue:9 Topics: Actuarial Analysis; Adrenergic beta-Antagonists; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Isosorbide Dinitrate; Ligation; Male; Middle Aged; Nadolol; Postoperative Complications; Regression Analysis; Secondary Prevention; Survival Analysis; Vasodilator Agents	2001
Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter The New England journal of medicine, 1991, May-30, Volume: 324, Issue:22 Topics: Adrenergic beta-Antagonists; Ascites; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Meta-Analysis as Topic; Middle Aged; Nadolol; Prognosis; Propranolol	1991
Nadolol for prevention of variceal rebleeding during the course of endoscopic injection sclerotherapy: a randomized pilot study. Journal of clinical gastroenterology, 1990, Volume: 12, Issue:3 Topics: Adult; Aged; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Nadolol; Pilot Projects; Random Allocation; Recurrence; Sclerotherapy	1990
[Beta-receptor blockaders in the prevention of hemorrhaging of esophageal varices?]. Deutsche medizinische Wochenschrift (1946), 1987, Aug-14, Volume: 112, Issue:33 Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Drug Evaluation; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Metoprolol; Nadolol; Placebos; Propranolol; Sclerosing Solutions	1987
Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial. Journal of hepatology, 1988, Volume: 7, Issue:1 Topics: Clinical Trials as Topic; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Male; Middle Aged; Nadolol; Patient Compliance	1988
Nadolol for prevention of variceal rebleeding in cirrhosis: a controlled clinical trial. Digestion, 1987, Volume: 37, Issue:1 Topics: Adult; Clinical Trials as Topic; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Nadolol; Random Allocation; Recurrence	1987

Other Studies

15 other study(ies) available for sq-11725 and Hematochezia

Article	Year
Primary prophylaxis of variceal bleeding. Hepatology international, 2018, Volume: 12, Issue:1 Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Nadolol; Propanolamines; Propranolol	2018
Risk and Predictors of Variceal Bleeding in Cirrhosis Patients Receiving Primary Prophylaxis With Non-Selective Beta-Blockers. The American journal of gastroenterology, 2016, Volume: 111, Issue:12 Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Ascites; Cohort Studies; Comorbidity; Dose-Response Relationship, Drug; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Heart Rate; Humans; Liver Cirrhosis; Male; Middle Aged; Nadolol; Primary Prevention; Proportional Hazards Models; Propranolol; Retrospective Studies; Risk Assessment; Risk Factors; United States; United States Department of Veterans Affairs	2016
A specialized, nurse-run titration clinic: a feasible option for optimizing beta-blockade in non-clinical trial patients. The American journal of gastroenterology, 2010, Volume: 105, Issue:9 Topics: Adrenergic beta-Antagonists; Ambulatory Care Facilities; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Nadolol; Practice Patterns, Nurses'; Propranolol; Prospective Studies; Treatment Outcome	2010
Evening administration of long-acting beta-blockers for primary prophylaxis in cirrhosis: an effective strategy. The American journal of gastroenterology, 2011, Volume: 106, Issue:3 Topics: Adrenergic beta-Antagonists; Delayed-Action Preparations; Drug Administration Schedule; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Nadolol; Primary Prevention; Propranolol; Treatment Outcome	2011
[Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding]. Zeitschrift fur Gastroenterologie, 2002, Volume: 40, Issue:7 Topics: Drug Therapy, Combination; Esophageal and Gastric Varices; Esophagoscopy; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Ligation; Nadolol; Randomized Controlled Trials as Topic; Recurrence	2002
Combined therapy for secondary prophylaxis of variceal rebleeding? The American journal of gastroenterology, 2002, Volume: 97, Issue:8 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemodynamics; Humans; Isosorbide Dinitrate; Ligation; Nadolol; Postoperative Complications; Randomized Controlled Trials as Topic; Recurrence; Survival Analysis; Vasodilator Agents	2002
Management of esophageal varices: an update from Digestive Disease Week and American Association for the Study of Liver Diseases 2003. Current gastroenterology reports, 2004, Volume: 6, Issue:3 Topics: Adrenergic beta-Antagonists; Disease Progression; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Ligation; Nadolol; Recurrence	2004
Management of cirrhosis and ascites. The New England journal of medicine, 2004, Jul-15, Volume: 351, Issue:3 Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Liver Cirrhosis; Nadolol; Propranolol; Secondary Prevention; Vasodilator Agents	2004
Nadolol versus band ligation for prevention of variceal bleeding. Gastrointestinal endoscopy, 2004, Volume: 60, Issue:6 Topics: Adrenergic beta-Antagonists; Chronotherapy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Ligation; Liver Cirrhosis; Nadolol; Randomized Controlled Trials as Topic; Treatment Outcome	2004
Effects of nadolol treatment on renal and hepatic hemodynamics and function in cirrhotic patients with portal hypertension. American heart journal, 1984, Volume: 108, Issue:4 Pt 2 Topics: Adrenergic beta-Antagonists; Blood Pressure; Cardiac Output; Diuresis; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Glomerular Filtration Rate; Humans; Hypertension, Portal; Liver Circulation; Liver Cirrhosis; Nadolol; Propanolamines; Renal Circulation	1984
Prevention of variceal rebleeding. The Journal of family practice, 1996, Volume: 43, Issue:3 Topics: Acute Disease; Adrenergic beta-Antagonists; Diuretics, Osmotic; Drug Combinations; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide Dinitrate; Nadolol; Randomized Controlled Trials as Topic; Recurrence; Reproducibility of Results; Sclerotherapy; Treatment Outcome	1996
Beta-blocker plus nitrate for primary prophylaxis of variceal bleeding. Gastroenterology, 2000, Volume: 119, Issue:4 Topics: Adrenergic beta-Antagonists; Blood Pressure; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Nadolol; Portal System; Propranolol	2000
Prevention of recurrent variceal bleeding. The New England journal of medicine, 2002, Jan-17, Volume: 346, Issue:3 Topics: Adrenergic beta-Antagonists; Endoscopy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Nadolol; Secondary Prevention	2002
Prevention of varices rebleeding: are drugs better after all? Gastroenterology, 2002, Volume: 122, Issue:3 Topics: Adrenergic beta-Antagonists; Diuretics, Osmotic; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Isosorbide; Nadolol; Recurrence	2002
Importance of the 1-month-effect of nadolol on portal pressure in predicting failure of prevention of rebleeding in cirrhosis. Journal of hepatology, 1991, Volume: 12, Issue:1 Topics: Esophageal and Gastric Varices; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Diseases; Male; Nadolol; Time Factors	1991